Skip to Content
Søk Menu

Jan Andreasen

Jan Andreasen is an educated doctor and journalist. He serves as the editor-in-chief of BestPractice Nordic in Denmark, Norway, Sweden, and Finland, and he has been involved in the dissemination of new knowledge within the field of medical science for over 25 years

Articles and MEDtalks

AML Insights – July-August Update: What’s New in the Field

  • / Amanda Feldballe Bernholm / Jan Andreasen

Nordic AML Insights – July-August Update

/ Amanda Feldballe Bernholm / Jan Andreasen
AML

New Data Support Osimertinib as a Backbone Treatment for EGFRm Advanced NSCLC

/ Jan Andreasen
LungekreftNSCLCWCLC25

Amivantamab + Lazertinib in EGFR-Mutated Advanced NSCLC: PALOMA-2 Update

/ Jan Andreasen
LungekreftNSCLCWCLC25

First-Line NSCLC Without Driver Mutations: Practice, Gaps, and Costs

/ Ronny Öhman / Jan Andreasen
LungekreftNSCLC

Verna: Lung Cancer Insights: What’s New in the Field

/ Jan Andreasen / Amanda Feldballe Bernholm

AML Insights – June Update: What’s New in the Field

/ Jan Andreasen
AML

Nordic AML Insights – June Update: Research and EHA Congress

/ Jan Andreasen
AMLAML-highlights

EAN 2025: GPT-4o Can’t Replace Doctors – But It Can Reduce Delays and Streamline the Treatment Process

/ Jan Andreasen
EAN25

EHA 2025: Improved Outcomes in High-Risk MCL with Acalabrutinib Combination Therapy 

/ Jan Andreasen
EHA25

Toward a New Standard of Care: Sacituzumab and Pembrolizumab in PD-L1+ mTNBC

/ Jan Andreasen
ASCO25NBCN
Load more
Back to top